BLACK WEEKSViale −15 % · kompleti −10 % · ostalo −5 %s kodoBrezplačna dostava v Nemčiji od 200 €

Ta stran je bila prevedena samodejno in lahko vsebuje napake. Ste materni govorec? Veseli bomo vaših povratnih informacij in popravkov.Pošljite povratne informacije

The Peptide Desk The Peptide Desk
LL-37, fotografija izdelka
Immune System

LL-37

Immune System

  • Odprema iz Nemčije

Naročilo

Cena na kos - Brezplačna dostava v Nemčiji od 200 € med Black Weeks
  • DHL s sledenjem
  • Diskretna embalaža

4.6 od 5 na Trustpilotu73 ocen

Na prvi pogled

LL-37 v številkah

Ključni podatki iz našega leksikona.

Celoten vnos v leksikonu
Class
Antimicrobial peptidecathelicidin
Half-life
short
Use
Subcutaneousin mcg
Sizes
5 to 10 mg2 sizes in the shop

Znanje

Vse o LL-37

Priporočljivo zraven

Kaj potrebujete zraven

Bakteriostatska voda se samodejno doda v vašo košarico. Brizge in robčki z enim klikom.

Inzulinske brizge

10 kos. · 5.50 €

Alkoholni robčki

50 kos. · 10 €

Koliko vode?

Enote na brizgi za vašo velikost viale.

Odpri kalkulator →

FAQ

Pogosta vprašanja

Viri za vsak odgovor: vnos v leksikonu

Imate še vprašanje?

Pišite nam, naša ekipa vam bo pomagala.

Is LL-37 approved or studied in humans?

Not approved, but tested in humans. Only locally though: applied to hard-to-heal leg ulcers (one trial with 34 and one with 148 participants) and as an injection into melanoma metastases (4 participants). There is no trial with LL-37 injected under the skin. The information here describes the state of research.

Where does LL-37 come from in the body?

It is cleaved from the precursor hCAP18. Immune cells make it all the time, skin and mucous membranes mainly during inflammation and infection. In wounds the level rises until about 48 hours after the injury and falls again once the wound has closed. Immune cells also make it depending on vitamin D.

How does LL-37 work?

In two ways. It attaches to the membrane of bacteria and breaks it open. It also attracts immune cells such as neutrophils, monocytes and T cells, via the receptor FPR2 in cell studies. In a skin model it helps wounds close with new skin.

What did the wound trials show?

In the first trial with 34 participants leg ulcers healed about six and three times faster than with placebo at the two lower concentrations, the mean area fell by 68 and 50 percent. The highest concentration worked no better than placebo. The larger phase 2b trial with 148 participants found no overall difference, only a post hoc analysis of large wounds favoured LL-37.

Can LL-37 increase inflammation?

Yes, that has been described. In rosacea cathelicidin is strongly raised in the facial skin and cut differently, in mice these fragments triggered inflammation. In psoriasis LL-37 binds the body's own DNA and makes it visible to certain immune cells, which then release interferon. The entry points this out too.

Which side effects are known?

In both wound trials LL-37 was well tolerated, there were no safety concerns at the wound or in the body. There are no study data for LL-37 injected under the skin. The entry mentions possible reactions at the injection site because LL-37 attacks cell membranes.

Sorodno

Sorodni izdelki